Higher levels of anti-phosphorylcholine autoantibodies in early rheumatoid arthritis indicate lower risk of incident cardiovascular events
Abstract Background The increased risk of cardiovascular events (CVE) in rheumatoid arthritis (RA) is not fully explained by traditional risk factors. Immuno-inflammatory mechanisms and autoantibodies could be involved in the pathogenesis of atherosclerotic disease. It has been suggested that anti-p...
Main Authors: | Sofia Ajeganova, Maria L. E. Andersson, Johan Frostegård, Ingiäld Hafström |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-07-01
|
Series: | Arthritis Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13075-021-02581-0 |
Similar Items
-
Novel autoantibodies in rheumatoid arthritis
by: A.F. Bonifacio, et al.
Published: (2019-04-01) -
Tuftsin-Phosphorylcholine Maintains Normal Gut Microbiota in Collagen Induced Arthritic Mice
by: Hila Ben-Amram, et al.
Published: (2017-07-01) -
The Clinical Value of Autoantibodies in Rheumatoid Arthritis
by: Serena Bugatti, et al.
Published: (2018-12-01) -
TNF, SOLUBLE RECEPTORS AND AUTOANTIBODIES TO TNF OF PATIENTS WITH RHEUMATOID ARTHRITIS AND HEALTHY DONORS
by: E. A. Golikova, et al.
Published: (2012-05-01) -
Clinical and pathophysiologic relevance of autoantibodies in rheumatoid arthritis
by: Sara de Brito Rocha, et al.
Published: (2019-01-01)